In addition, whether it is the original brain tumor mouse model or the mouse brain infiltrating lymphocytes inoculated with GL261-FGL2, compared with the control model, the number of MDSC, M2 and CD39+Treg increased 72, indicating that FGL2 reinforces tumor immunosuppression. Here, FGL2 is linked to brain neoplasm.